Real-world effectiveness of lenvatinib monotherapy in previously treated unresectable hepatocellular carcinoma in US clinical practice.

Amit G SingalSaurabh P NagarAbby HitchensKeith L DavisShrividya Iyer

Published in: Cancer reports (Hoboken, N.J.) (2022)

This retrospective study suggests clinical effectiveness of lenvatinib monotherapy in a real-world setting among previously treated patients with uHCC, including among those previously treated with immunotherapy.

Keyphrases

randomized controlled trial
clinical practice
systematic review
combination therapy
open label
newly diagnosed
squamous cell carcinoma
clinical trial
locally advanced
study protocol